Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma

Metabolic reprogramming is a novel method for the treatment of malignant tumors. The exploration of metabolism procedures between radiosensitive and radioresistant tumors may provide novel perspectives for lung adenocarcinoma (LUAD) patients after radiation therapy. In our study, metabolic reprogram...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shun-Li, Wang, Rong, Zhou, Yu-Ling, Wei, Wei, Zhong, Gui-Hua, Huang, Xiao-Tao, Yang, Shuai, Liu, Qiao-Dan, Liu, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262104/
https://www.ncbi.nlm.nih.gov/pubmed/35812404
http://dx.doi.org/10.3389/fimmu.2022.872910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262104/
https://www.ncbi.nlm.nih.gov/pubmed/35812404
http://dx.doi.org/10.3389/fimmu.2022.872910

Ejemplares similares